So, we decided to scrutinise the cytokine secretion of CAF-200 cells in order to find out whether the induction of resistance to anti-HER2 therapy in tumour cells was related to cytokine production by CAFs under TPD treatment situations. Here, ERBB2 is linked to neoplasm.